Form 8-K - Current report:
SEC Accession No. 0001299933-11-001360
Filing Date
2011-05-05
Accepted
2011-05-05 16:17:28
Documents
3
Period of Report
2011-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_41604.htm 8-K 10634
2 EX-99.1 exhibit1.htm EX-99.1 72567
3 GRAPHIC e33462-11125123112791fb9c_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-11-001360.txt   121443
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 11814895
SIC: 2834 Pharmaceutical Preparations